Drug intelligence / Profile preview

Counterpain

Development stage
Unknown
Lead developer
Taisho Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Counterpain is a topical analgesic product line developed and manufactured by Taisho Pharmaceutical, primarily marketed in Thailand and other Southeast Asian regions. It is indicated for the temporary relief of minor muscle and joint pain associated with strains, bruises, sprains, arthritis, and backaches. The product is available in several formulations, including Counterpain Original (Warm), Counterpain Cool, and Counterpain Plus. The standard formulation contains a combination of methyl salicylate, menthol, and eugenol. Methyl salicylate acts as a counter-irritant and anti-inflammatory agent by inhibiting prostaglandin synthesis, while menthol provides a cooling sensation through the activation of TRPM8 receptors to alleviate pain perception. The Counterpain Plus variant incorporates piroxicam, a nonsteroidal anti-inflammatory drug (NSAID) that provides enhanced relief by inhibiting cyclooxygenase (COX) enzymes at the site of application.

Brand names
CounterpainCounterpain OriginalCounterpain CoolCounterpain Plus
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Counterpain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Counterpain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call